Endogenous Opiates Participate in the Regulation of Pulsatile Luteinizing Hormone Release in an Unopposed Estrogen Milieu: Studies in Estrogen-Replaced, Gonadectomized Patients with Testicular Feminization*
- 1 October 1985
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 61 (4) , 790-793
- https://doi.org/10.1210/jcem-61-4-790
Abstract
Administration of opiate receptor antagonists augmented pulsatile LH release in six estrogen-treated, orchidectomized individuals with testicular feminization. In response to an opiate antagonist, LH pulse frequency increased from 3.0 ± 0.55 (±SE) to 5.0 ± 0.45 pulses/8 h (P = 0.034). Since these patients have inborn target tissue resistance to androgens, we infer that sustained androgen action is not obligatory to the emergence of endogenous inhibitory opiate tone in man. Rather, these observations document that the suppressive effects of opiates on gonadotropin secretion can be unmasked in the presence of an unopposed estrogen milieu.Keywords
This publication has 15 references indexed in Scilit:
- Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.Journal of Clinical Investigation, 1983
- Estradiol Modulation of Basal and Gonadotropin-Releasing Hormone-Induced Gonadotropin Release in Intact and Castrated MenNeuroendocrinology, 1983
- THE TEMPORAL RELATIONSHIP BETWEEN GONADOTROPIN RELEASING HORMONE (GnRH) AND LUTEINIZING HORMONE (LH) SECRETION IN OVARIECTOMIZED EWES1Endocrinology, 1982
- Luteinizing Hormone-Releasing Hormone Release during the Rat Estrous Cycle and after Ovariectomy, as Estimated with Push-Pull Cannulae*Endocrinology, 1982
- Responsiveness of Gonadotropin Secretion to Infusion of an Opiate-Receptor Antagonist in Hypogonadotropic Individuals*Journal of Clinical Endocrinology & Metabolism, 1982
- Effect of Endogenous Opioid Blockade on the Amplitude and Frequency of Pulsatile Luteinizing Hormone Secretion in Normal Men*Journal of Clinical Endocrinology & Metabolism, 1982
- Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.Journal of Clinical Investigation, 1980
- Dopaminergic Mechanisms and Luteinizing Hormone Secretion. I. Acute Administration of the Dopamine Agonist Bromocriptine Does Not Inhibit Luteinizing Hormone Release in Hyperprolactinemic Women*Journal of Clinical Endocrinology & Metabolism, 1980
- Endogenous Opioids Participate in the Regulation of the Hypothalamic-Pituitary-Luteinizing Hormone Axis and Testosterone's Negative Feedback Control of Luteinizing Hormone*Endocrinology, 1979
- MODULATION OF PITUITARY RESPONSIVENESS TO EXOGENOUS LHRH BY AN OESTROGENIC AND AN ANTI‐OESTROGENIC COMPOUND IN THE NORMAL MALEClinical Endocrinology, 1976